Russell Parker, DO
Family Medicine · Kamuela, HINPI 1023167947
Payments from drug & device makers
Across 17 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$49
- Jazz Pharmaceuticals Inc.$38
- Novo Nordisk$34
- Biohaven Pharmaceuticals, Inc.$33
- Gilead$29
- Viiv Healthcare Company$27
- plus $96 from 6 others
What the payments were for
- Food & beverage$307100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 2 | $49 |
| Jazz Pharmaceuticals Inc. | 2 | $38 |
| Novo Nordisk | 2 | $34 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| Gilead | 2 | $29 |
| Viiv Healthcare Company | 1 | $27 |
| Exact Sciences | 1 | $24 |
| Bioventus LLC | 1 | $18 |
| Merck | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
| Janssen Scientific Affairs, LLC | 1 | $12 |
| EMD Serono, Inc. | 1 | $12 |
How this compares
$307 in reported general payments places this provider in the 55th percentile of 376 family medicine providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 112 | $17,959 |
| Nucynta ErTapentadol Hcl | 16 | $14,616 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 355 | $12,117 |
| LyricaPregabalin | 12 | $11,227 |
| Oxycodone Hcl | 489 | $8,414 |
| Morphine Sulfate ErMorphine Sulfate | 200 | $7,056 |
| Buprenorphine Hcl | 134 | $4,524 |
| FlectorDiclofenac Epolamine | 13 | $4,243 |
| Morphine Sulfate | 110 | $2,714 |
| Gabapentin | 152 | $2,651 |
| Naloxone Hcl | 36 | $2,077 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 85 | $2,032 |
| Pregabalin | 54 | $1,043 |
| Tizanidine Hcl | 82 | $1,020 |
| Lidocaine | 13 | $916 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Kamuela
- Michele ShimizuKamuela$3K
- Hugh MooreKoloa$237K
- Brian StolleyKihei$126K
- Vicente RamoHonolulu$34K
- Johnnie YatesHonolulu$25K
- Edward AlqueroWaipahu$24K
- Noelani HobbsWaipahu$23K
- Rainier Dennis BautistaLihue$23K
- Choon YeoHonolulu$20K
- Buddy FesterlingHilo$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.